You are here: Industry Insights > COVID-19

News List

More Flights Canceled as Omicron Continues to Hit Flight Crews drugs
December 27, 2021
The omicron variant continued to keep flights grounded on Monday as airlines canceled at least 2,400 more flights around the world, including 900 in the United States.
Omicron Cases Pass U.S. Peak Seen With Delta drugs
December 27, 2021
OVID-19 is again surging throughout the United States, with the omicron variant already outpacing this summer's delta variant in the rate of daily cases.
COVID-19-Related Alcohol Consumption Will Increase Liver Disease drugs
December 27, 2021
The short-term increase in alcohol consumption during the COVID-19 pandemic is expected to substantially increase the morbidity and mortality associated with long-term alcohol-related liver disease.
Chinese mainland reports 71 locally transmitted COVID-19 cases NMPA/Xinhua
December 24, 2021
The Chinese mainland on Wednesday reported 71 new locally transmitted COVID-19 cases, the National Health Commission said in its daily report on Dec 23.
Meridian Donates 900 Box Lunches to Spectrum Health Workers prnewswire
December 24, 2021
Meridian Health Plan of Michigan teamed up with Apple Spice Catering Company to provide 900 box lunches for Spectrum Health employees as a thank you for their dedicated efforts to care for the community during the COVID-19 pandemic.
Pfizer to deliver 2.5 million additional doses of Covid-19 pill to UK Pharmaceutical-Business-Review
December 24, 2021
The agreement with the Government of the UK is subject to the local authorisation of the Covid-19 pill.
FDA grants EUA for Pfizer’s Covid-19 oral antiviral Paxlovid Pharmaceutical-Technology
December 24, 2021
The US Food and Drug Administration (FDA) has granted an emergency use authorization (EUA) for Pfizer’s oral antiviral Paxlovid to treat mild-to-moderate Covid-19 in adults and paediatric individuals aged 12 years and above.
BiondVax signs deals to develop nanosized Covid-19 antibodies Pharmaceutical-Technology
December 24, 2021
BiondVax Pharmaceuticals has entered definitive agreements with the Max Planck Society (MPG) and the University Medical Center G?ttingen (UMG) in Germany to develop and market novel Covid-19 nanosized antibodies (NanoAbs).
HKU teams develop the first anti-COVID-19 stainless steel prnasia
December 23, 2021
The project team led by Professor Mingxin HUANG at the Department of Mechanical Engineering of the Faculty of Engineering of the University of Hong Kong, S.A.R., China (HKU)...
Coronavirus (COVID-19) Update: FDA Authorizes First Oral Antiviral for Treatment of COVID-19 prnewswire
December 23, 2021
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer's Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate coronavirus disease...